Clinical Trial Update: Mapsd Dual-target cTBS (Auditory Cortex and M1) for Generalized Anxiety Disorder [NA]

View source ↗

Summary

A clinical trial update for Mapsd Dual-target cTBS targeting the auditory cortex and primary motor cortex for Generalized Anxiety Disorder; the study is not yet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Generalized Anxiety Disorder

Drugs mentioned

• Mapsd Dual-target cTBS (Auditory Cortex and M1)

Snippet

Sponsor: Anhui Medical University | Conditions: Generalized Anxiety Disorder | NA | Status: NOT_YET_RECRUITING